Giorgia T. Maniscalco
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 122 publications
Predictive factors of response to anti-CGRP pathway drugs in people with multiple sclerosis.
Journal: The journal of headache and pain
Published: May 10, 2026
Validation of the MOG-AR Score: A Retrospective Multicenter Study.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 28, 2026
Multiple sclerosis patients under treatment with interferon β1-a or ocrelizumab exhibit different T and B cell responses to SARS-CoV-2 vaccine.
Journal: Frontiers in immunology
Published: December 22, 2025
HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMS.
Journal: Journal of neurology
Published: December 05, 2025
Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 monoclonal antibodies: a systematic review and meta-analysis of observational studies.
Journal: Expert opinion on drug safety
Published: October 13, 2025
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 19, 2025
Occurrence of myoclonus in multiple sclerosis - Pathogenetic insights: A new case and review of literature.
Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Published: June 29, 2025
The Italian Multiple Sclerosis Register Experience With Cladribine: Impact on Relapses, PIRA, and Treatment Sequencing Strategies Evaluation.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: June 05, 2025
Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study.
Journal: Journal of neurology
Published: May 23, 2025
Hypogammaglobulinemia in patients with multiple sclerosis receiving disease modifying therapies: disproportionality analysis using the EudraVigilance database.
Journal: Expert opinion on drug safety
Published: April 16, 2025
CD4+FOXP3Exon2+ regulatory T cell frequency predicts breast cancer prognosis and survival.
Journal: Science advances
Published: January 15, 2025
Last Updated: 09/26/2026